European Archives - Page 326 of 1101 - European Medical Journal

Current Treatment and Emerging Solutions in IgA Nephropathy

IgAN, which can lead to CKD and kidney failure, is the most common form of primary glomerulonephritis, predominantly…

Can COVID-19 Help Us Deliver Whole-System Holistic Healthcare?

Marc Evans, University Hospital Llandough, Cardiff, UK, opened the session by highlighting the growing costs and prevalence of diabetes…

Spasticity Following Acute Stroke

Many patients experience impairment following a stroke, including motor or cognitive impairment, urinary incontinence, dysphagia…

Tackling Becker Muscular Dystrophy

First described by German physician Peter Emil Becker in the 1950s, Becker is an X-linked genetic recessive disorder. Like Duchenne…

Methotrexate for Rheumatoid Arthritis

Methotrexate is a common first-line treatment for rheumatoid arthritis, yet its widespread and habitual usage often leads physicians…

Empowering Women Through Menopausal Awareness

While awareness of the issues facing women leading up to, during, and following the menopause has increased in recent years…

Redefining Renal Cell Carcinoma

Renal cell carcinoma (RCC) is the most common primary tumour originating from the kidney, and accounts for more than 90% of all renal…

Liraglutide for Obesity in Type 2 Diabetes

Obesity is a major risk factor for the development of Type 2 diabetes (T2D), with the prevalence of both increasing in a parallel manner…

Autologous Transplant or Chimeric Antigen Receptor T Cell Therapy for Patients with Relapsed/Refractory Large B-cell Lymphoma: How to Choose?

Expert Madiha Iqbal, Consultant and Assistant Professor of Medicine, Mayo Clinic, Jacksonville, Florida, USA, presents on the treatment…

How to Translate Science into Patient Care: Long Term Outcomes in Clinical Trials

Watch our latest webinar on-demand now, exploring the ways in which clinical decision making is affected by long term outcomes in…